Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 44.61
-0.999 %
$ 2.14 B
Market Cap
14.82
P/E
CASH FLOW STATEMENT
184 M
OPERATING CASH FLOW
-649 M
INVESTING CASH FLOW
454 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Amphastar Pharmaceuticals, Inc.
| Net Income | 138 M |
| Depreciation & Amortization | 41.8 M |
| Capital Expenditures | -38.2 M |
| Stock-Based Compensation | 20.2 M |
| Change in Working Capital | -24.2 M |
| Others | 11.1 M |
| Free Cash Flow | 145 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | 137.5 | 91.4 | 63.3 | 1.1 | 46.5 | (6.7) | 4.5 | 10.5 | (2.8) | (10.7) | 11.9 | 18.1 | 7.8 |
| Depreciation & Amortization | 41.8 | 28.7 | 26.8 | 25.2 | 21.1 | 16.5 | 15.4 | 14.6 | 13.3 | 14.4 | 13.1 | 11.5 | 11.2 |
| Deferred Income Tax | (12.6) | (15.8) | 4.2 | 1.1 | 7.6 | (1.9) | 3.9 | (3.3) | (7.9) | (8.2) | 2.1 | 8.3 | (36.0) |
| Stock Based Compensation | 20.2 | 17.9 | 18.7 | 20.5 | 17.3 | 16.7 | 17.1 | 15.1 | 12.8 | 9.3 | 7.0 | 7.4 | 8.0 |
| Other Operating Activities | 20.7 | (0.9) | (13.0) | 0.2 | 1.0 | 1.4 | (2.3) | 1.3 | 0.4 | 0.6 | 0.2 | 2.7 | 0.6 |
| Change in Working Capital | (24.2) | (32.2) | (1.9) | 9.1 | (51.7) | 12.1 | 0.6 | 0.3 | (5.1) | 15.6 | (3.2) | (49.6) | 27.6 |
| Cash From Operations | 183.5 | 89.2 | 98.0 | 57.3 | 41.8 | 38.2 | 39.2 | 38.6 | 10.7 | 21.1 | 31.0 | (1.6) | 19.1 |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (38.2) | (24.0) | (27.5) | (33.9) | (41.6) | (46.8) | (35.1) | (21.4) | (16.0) | (20.5) | (18.3) | (25.2) | (10.7) |
| Other Items | (611.0) | (8.7) | (1.2) | (2.6) | (9.0) | 4.6 | (3.7) | (18.1) | (0.9) | (19.3) | 4 K | 0.1 | 0.2 |
| Cash From Investing Activities | (649.1) | (32.8) | (28.7) | (36.4) | (50.5) | (42.2) | (38.8) | (39.5) | (16.9) | (39.8) | (18.3) | (25.1) | (10.5) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | (58.1) | (39.9) | (28.9) | (24.4) | (22.3) | (25.0) | (30.7) | (9.9) | (9.9) | (0.7) | (0.2) | (0.8) | (1.8) |
| Total Debt Repaid | 526.3 | (1.8) | 32.1 | (0.9) | (3.2) | 3.1 | 9.3 | (4.5) | (2.2) | (2.7) | (8.6) | 23.8 | (5.9) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (14.1) | 15.3 | (40.2) | 23.1 | 3.4 | 8.9 | 13.8 | 21.5 | 14.3 | 35.2 | (0.6) | 0.2 | (0.9) |
| Cash From Financing Activities | 454.1 | (26.4) | (37.0) | (2.2) | (3.8) | 25.0 | (7.7) | 7.1 | 2.2 | 32.1 | (9.4) | 23.2 | (8.6) |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | (11.8) | 29.7 | 32.1 | 19.0 | (12.7) | 20.7 | (6.8) | 6.3 | (1.8) | 14.2 | 3.4 | (3.5) | 15 K |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | 145.3 | 65.1 | 70.5 | 23.4 | 0.2 | (8.6) | 4.1 | 17.2 | (5.4) | 0.6 | 12.7 | (26.9) | 8.4 |